Please select a region
Manage Consent Preferences
Cookie Details
Strictly Functional Cookie
Analytics Cookie
Targeting Cookie
Back
Analytics Cookies
x
Cookies List
Our site is undergoing a scheduled maintenance from 30th December 2020 to 3rd January 2021 and some functionalities will not be available at this time
Loading your cart..
-
Products
Products
-
Services
Services
-
-
Challenges
Challenges
-
Reducing Total Cost of Ownership
Solving the Challenge of High pH Injectable Drug ProductsClick HerePackaging Solutions for Sensitive Molecules
Solving the Challenge of Single-Use Large-Volume Delivery for Patient Self-Injection
-
-
Support
Support
-
Fill-Finish Support ServicesThrough our Integrated Solutions program and collaborations with equipment manufacturers and Contract Manufacturing Organizations (CMOs), West can assist drug developers with fill-finish services.Fill-Finish Support ServicesKnowledge CenterThe West Knowledge Center provides scientific insight and more detailed technical information on key areas of expertise featuring technical reports, bulletins and science posters.Knowledge Center
-
Services
Challenges

Solving the Challenge of High pH Injectable Drug Products
Click Here

Solving the Challenge of Single-Use Large-Volume Delivery for Patient Self-Injection
Support
Fill-Finish Support Services
Through our Integrated Solutions program and collaborations with equipment manufacturers and Contract Manufacturing Organizations (CMOs), West can assist drug developers with fill-finish services.
Fill-Finish Support Services
Knowledge Center
The West Knowledge Center provides scientific insight and more detailed technical information on key areas of expertise featuring technical reports, bulletins and science posters.
Knowledge Center
Latest Post
April 09, 2021
Vial Compatibility with Closed System Transfer Devices
Unanticipated incompatibilities between the drug product and a closed system transfer device (CSTD) delay therapeutic delivery to the patient. Considering the CSTD with the drug product and even co-packaging the drug product with an optimal FDA-approved CSTD will positively impact drug product therapeutic performance and ultimately patient care.

Aaron Chapman PhD
Program Manager, Commercial Technology Development
Previous Posts

March 10, 2021
Biosimilars Market Survey Brings Insight to Most Important Containment and Support Service Needs

Abbey Hisler
Director, Strategic Marketing, Biologics

February 02, 2021
Why FluroTec® Barrier Film for Lyophilization Stoppers

Deolinda Martins
Manager, Technical Accounts, TCS

January 11, 2021
SG EZ-fill® Glass Vials Now Available in Online Store

Carol Mooney
Director, Commercial Digital Transformation
Load more
Loading...